Topical glucocorticoid or pimecrolimus treatment suppresses thymic stromal lymphopoietin-related allergic inflammatory mechanism in an oxazolone-induced atopic dermatitis murine model

Archives of Dermatological Research
Na Young YoonEung Ho Choi

Abstract

Congenitally or early impaired skin barrier as the first event starting the 'atopic march' in atopic dermatitis (AD) patients can increase allergen penetration that results in sensitization, even in the airways, followed by asthma and allergic rhinitis. Thymic stromal lymphopoietin (TSLP) is a cytokine existing in high levels in AD skin and is considered as a novel therapeutic target for atopic disease. We generated oxazolone (Ox)-induced AD-like (Ox-AD) hairless mice and divided them into four groups according to the therapeutic challenges: topical glucocorticoid, pimecrolimus, emollient, and control (acetone-only treated). We assessed the functional studies of skin barrier, epidermal expressions of differentiation markers, IL-1α, TNF-α, proteinase-activated receptor-2 (PAR-2), TSLP and antimicrobial peptides (AMP), and serum IgE in each group. Topical glucocorticoid or pimecrolimus treatment improved AD-like skin lesions and barrier functions, and restored the epidermal expression of differentiation markers, IL-1α, TNF-α, PAR-2, and TSLP, in Ox-AD mice. The improvement was relatively better with the glucocorticoid than pimecrolimus. Epidermal AMP expression was restored by topical glucocorticoid, but not pimecrolimus. Our res...Continue Reading

References

Aug 1, 1992·The Journal of Clinical Investigation·L C WoodK R Feingold
Sep 5, 2002·Nature Reviews. Molecular Cell Biology·Mark E Fortini
Oct 11, 2002·The New England Journal of Medicine·Peck Y OngDonald Y M Leung
Dec 6, 2003·The Journal of Allergy and Clinical Immunology·Jonathan M Spergel, Amy S Paller
Jan 25, 2006·The Journal of Experimental Medicine·Yong-Jun Liu
Aug 2, 2006·Proceedings of the National Academy of Sciences of the United States of America·Mei LiPierre Chambon
Feb 27, 2007·The Journal of Allergy and Clinical Immunology·Susanne EbnerNikolaus Romani
Oct 19, 2007·The Journal of Investigative Dermatology·Karin M AbergPeter M Elias
Aug 20, 2008·Proceedings of the National Academy of Sciences of the United States of America·Rui HeRaif S Geha
Mar 24, 2009·Journal of Dermatological Science·Mohammad Maged Y El-BatawyVanessa Suzan G A Hafez
Jun 6, 2009·The Journal of Investigative Dermatology·Michael J CorkSimon J Ward
Jun 27, 2009·PLoS Biology·Shadmehr DemehriRaphael Kopan
Jun 30, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hideaki KouzakiHirohito Kita
Mar 20, 2010·Nature Immunology·Steven F Ziegler, David Artis
May 4, 2010·Dermato-endocrinology·Bodo C Melnik
May 7, 2010·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Eun Byoul LeeKyu-Earn Kim
Aug 13, 2010·The Journal of Investigative Dermatology·Anaïs BriotAlain Hovnanian
Nov 26, 2010·The Journal of Investigative Dermatology·Ye-Jin JungEung Ho Choi
Nov 1, 1997·Environmental Toxicology and Pharmacology·R L BergmannK E Bergmann
May 9, 2012·The Journal of Experimental Medicine·Claus-Werner FranzkeCarl P Blobel
May 16, 2012·European Journal of Immunology·Yanlu ZhangBaohua Zhou
May 24, 2014·Acta Dermato-venereologica·Bodo C Melnik

❮ Previous
Next ❯

Citations

May 5, 2016·BioMed Research International·Marina Jovanović, Zoran Golušin
Oct 13, 2017·International Journal of Molecular Sciences·Tzu-Kai LinJuan Luis Santiago
Sep 6, 2018·Immunopharmacology and Immunotoxicology·Na-Ra HanHyun-Ja Jeong
Jan 30, 2019·Dermatologic Therapy·Griffin R LeeVivian Y Shi
Jul 10, 2019·Experimental Dermatology·Takamichi KakeNoriko Takahashi
Feb 11, 2021·Journal of Clinical Medicine·Justin ChoiMadan M Kwatra
Dec 29, 2020·Experimental Dermatology·Amos GilharRalf Paus

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Allergies & Environmental Factors

Environmental factors are strongly associated with the prevalence of allergies and are an increasing health concern worldwide. Discover the latest research on Allergies and Environmental Factors here.

Related Papers

Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
Konstantinos-Dionysios AlysandratosTheoharis C Theoharides
Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery
Meili Xu, Yongqing Guo
© 2021 Meta ULC. All rights reserved